§ BIOTECHNOLOGY
USD · BiotechnologyKALV
KALVISTA PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · 0.05
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
1 increased/new, 0 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 7.18 | EPS (TTM) | -1.58 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| VR ADVISER, LLC | 6.5M | 4.9% | −4% |
| Frazier Life Sciences Management, L.P. | 5.0M | 2.6% | −2% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4.8M | 2.5% | ±0% |
| TANG CAPITAL MANAGEMENT LLC | 4.6M | 4.7% | ±0% |
| BlackRock | 3.8M | 0.0% | +1% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.9M | 5.9% | +19% |
◇ AC INTELLIGENCE
Top institutional owners for KALV as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER114.1% · 136 holders
DEALER / BANK12.2% · 20 holders
PASSIVE / INDEX10.4% · 7 holders
QUALITY / COMPOUNDER7.9% · 10 holders
TACTICAL / MACRO4.1% · 3 holders
SYSTEMATIC / QUANT0.7% · 4 holders
INCOME / DEFENSIVE0.1% · 5 holders
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for KALV in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention KALV yet.